Aarhus University Hospital / Aarhus Universitetshospital

Hospital


Location: Aarhus, Denmark (DK) DK

ISNI: 000000040512597X

ROR: https://ror.org/040r8fr65

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Integrated prediction of lesion-specific ischaemia from quantitative coronary CT angiography using machine learning: a multicentre study (2018) Dey D, Gaur S, Ovrehus KA, Slomka PJ, Betancur J, Goeller M, Hell MM, et al. Journal article Is MED13L-related intellectual disability a recognizable syndrome? (2018) Tørring PM, Larsen MJ, Brasch-Andersen C, Krogh LN, Kibæk M, Laulund L, Illum N, et al. Journal article FOXM1 predicts disease progression in non-muscle invasive bladder cancer (2018) Rinaldetti S, Wirtz R, Worst TS, Hartmann A, Breyer J, Dyrskjot L, Erben P Journal article Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups (2018) Van Kessel KEM, Van Der Keur KA, Dyrskjot L, Algaba F, Welvaart NYC, Beukers W, Segersten U, et al. Journal article Cardiac MR angiography (2017) Prieto C, Makowski MR, Kim WY, Manning WJ, Botnar RM Authored book Comparison of linear and nonlinear implementation of the compartmental tissue uptake model for dynamic contrast-enhanced MRI (2017) Kallehauge JF, Sourbron S, Irving B, Tanderup K, Schnabel JA, Chappell MA Journal article Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents (2017) Harada Y, Michel J, Lohaus R, Mayers K, Emmer R, Lahmann AL, Colleran R, et al. Journal article European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes (2017) Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, et al. Journal article Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017) Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, et al. Journal article Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass (2017) Keaveny TM, Crittenden DB, Bolognese MA, Genant HK, Engelke K, Oliveri B, Brown JP, et al. Journal article